Clinical Benefit of Insulin Glargine 300 U/mL Among Patients with Type 2 Diabetes Mellitus Previously Uncontrolled on Basal or Premixed Insulin in Serbia: A Prospective, Observational, Single-Arm, Multicenter, Real-World Study

INTRODUCTION: Insulin glargine 300 U/mL (Gla-300) is a novel glargine formulation which shows slower and more prolonged absorption following subcutaneous administration in comparison to insulin glargine 100 U/mL. In this prospective, observational, single-arm, multicenter, real-world study conducted...

Descripción completa

Detalles Bibliográficos
Autores principales: Velojic-Golubovic, Milena, Ciric, Vojislav, Dimitrijevic, Marija, Kovic, Tijana, Mitic, Milica, Olujic, Biljana, Pevac, Natasa, Radenkovic, Sasa, Radojkovic, Danijela, Vukadinovic, Selena, Popovic, Djordje S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266919/
https://www.ncbi.nlm.nih.gov/pubmed/34160790
http://dx.doi.org/10.1007/s13300-021-01074-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266919/
https://www.ncbi.nlm.nih.gov/pubmed/34160790
http://dx.doi.org/10.1007/s13300-021-01074-2

Ejemplares similares